WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Shane Crippen
Associate
Patents and Innovations
Boulder
scrippen@wsgr.com

D415-947-2019

Download vCard
Open PDF

Dr. Shane Crippen is an associate in the Boulder office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations group. He focuses on patent prosecution and counseling.

Prior to joining the firm, Shane served in the U.S. Air Force as a command pilot, professor of electrical engineering, and member of the Parachute Team Wings of Blue. While in the Air Force, he completed his doctoral degree in electrical engineering. During his doctoral research, he coupled droplet microfluidic devices with high speed imaging to characterize the biomechanical properties of single cancer cells. His research validated real world microdevices with numerical simulation and modeling. During his master’s research, he coupled microfluidic devices with dielectrophoresis to understand the response of DNA to nonuniform electric fields. After leaving the Air Force, he joined a start-up company developing a nanotechnology-based, cancer theranostic. His law school studies focused on IP law, business and corporate law, and venture capital and corporate finance.

Shane’s background as a seasoned Air Force pilot and operator provides a unique advantage for his aerospace clients. Shane’s hands-on experience in the aerospace field equips him with a deep understanding of the nuances involved in aerospace technology. This enables him to offer aerospace clients a perspective that bridges the gap between law and the highly technical aspects of the aerospace industry. In addition to patent advice, Shane offers strategic guidance rooted in real-world experience, adding remarkable value to his aerospace clients.

Experience

Dr. Shane Crippen is an associate in the Boulder office of Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations group. He focuses on patent prosecution and counseling.

Prior to joining the firm, Shane served in the U.S. Air Force as a command pilot, professor of electrical engineering, and member of the Parachute Team Wings of Blue. While in the Air Force, he completed his doctoral degree in electrical engineering. During his doctoral research, he coupled droplet microfluidic devices with high speed imaging to characterize the biomechanical properties of single cancer cells. His research validated real world microdevices with numerical simulation and modeling. During his master’s research, he coupled microfluidic devices with dielectrophoresis to understand the response of DNA to nonuniform electric fields. After leaving the Air Force, he joined a start-up company developing a nanotechnology-based, cancer theranostic. His law school studies focused on IP law, business and corporate law, and venture capital and corporate finance.

Shane’s background as a seasoned Air Force pilot and operator provides a unique advantage for his aerospace clients. Shane’s hands-on experience in the aerospace field equips him with a deep understanding of the nuances involved in aerospace technology. This enables him to offer aerospace clients a perspective that bridges the gap between law and the highly technical aspects of the aerospace industry. In addition to patent advice, Shane offers strategic guidance rooted in real-world experience, adding remarkable value to his aerospace clients.

Education
  • J.D., UC Berkeley School of Law
  • Ph.D. Electrical Engineering, Stanford University
  • M.S., Electrical Engineering, University of Washington
  • B.S., Electrical Engineering, U.S. Air Force Academy
Admissions
  • State Bar of Colorado
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., UC Berkeley School of Law
  • Ph.D. Electrical Engineering, Stanford University
  • M.S., Electrical Engineering, University of Washington
  • B.S., Electrical Engineering, U.S. Air Force Academy
Admissions
  • State Bar of Colorado
  • U.S. Patent and Trademark Office

Diagnostics and Medical Devices

  • Biomedical devices
  • Biosensors
  • Diagnostics
  • Medical devices

Engineering and Technology

  • AI
  • Electrical engineering
  • Machine learning
  • Microfluidics
  • Robotics

Miscellaneous

  • Physics
Technical Fluency

Diagnostics and Medical Devices

  • Biomedical devices
  • Biosensors
  • Diagnostics
  • Medical devices

Engineering and Technology

  • AI
  • Electrical engineering
  • Machine learning
  • Microfluidics
  • Robotics

Miscellaneous

  • Physics
Focus Areas
  • Artificial Intelligence and Machine Learning
  • Diagnostics, Life Science Tools, and Deep Tech
  • Life Sciences
  • Medical Devices
  • NewSpace
  • Patents and Innovations
  • Semiconductors
Recent Insights
Client Highlights
Wilson Sonsini Advises Scipher Medicine on Patent Matters Related to $110 Million Financing
On February 24, 2022, Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, announced the completion of a $110 million financing. The round is led by Cowen Healthcare Investments, with participation from new investors Neuberger Berman, Hitachi Ventures, Laurion Capital, and Monashee Investment Management. Existing investors Northpond Ventures, aMoon, Khosla Ventures, Optum Ventures, Echo Health Ventures, and Alumni Ventures also are participating. Scipher has raised $227 million total to date. Wilson Sonsini Goodrich & Rosati advised Scipher Medicine on patent matters related to the transaction.
Learn More
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.